David Kirn

Insider Reports History

Entity
Individual
Location
C/O 4 D Molecular Therapeutics Inc., 5858 Horton Street #455, Emeryville, CA
Signature
By: /s/ Scott Bizily as Attorney-in-fact David Kirn
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Kirn:

Stock Role Class Num Shares Value Price $ Report Date Ownership
4D Molecular Therapeutics, Inc. Chief Executive Officer, Director Common Stock 1.06M $23.8M $22.49 Jul 10, 2024 Direct
4D Molecular Therapeutics, Inc. Chief Executive Officer, Director Stock Option (Right To Buy) 149K Jul 10, 2024 Direct

Insider Reports Filed by David Kirn

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FDMT 4D Molecular Therapeutics, Inc. Jul 10, 2024 5 -$103K 4 Jul 12, 2024 Chief Executive Officer, Director
FDMT 4D Molecular Therapeutics, Inc. Jun 24, 2024 3 -$112K 4 Jun 26, 2024 Chief Executive Officer, Director
FDMT 4D Molecular Therapeutics, Inc. Feb 8, 2024 1 -$2.5M 4 Feb 12, 2024 Chief Executive Officer, Director
FDMT 4D Molecular Therapeutics, Inc. Jan 23, 2024 1 -$105K 4 Jan 25, 2024 Chief Executive Officer, Director
FDMT 4D Molecular Therapeutics, Inc. Dec 15, 2023 5 -$1.96M 4 Jan 8, 2024 Chief Executive Officer, Director
FDMT 4D Molecular Therapeutics, Inc. Dec 11, 2023 1 $0 4 Dec 13, 2023 Chief Executive Officer, Director
FDMT 4D Molecular Therapeutics, Inc. May 2, 2023 2 $0 4 May 4, 2023 Chief Executive Officer, Director
FDMT 4D Molecular Therapeutics, Inc. Feb 21, 2023 3 -$710K 4 Feb 23, 2023 Chief Executive Officer, Director
FDMT 4D Molecular Therapeutics, Inc. Feb 10, 2023 1 $0 4 Feb 14, 2023 Chief Executive Officer, Director
FDMT 4D Molecular Therapeutics, Inc. Jan 19, 2023 2 -$392K 4 Jan 23, 2023 Chief Executive Officer, Director
FDMT 4D Molecular Therapeutics, Inc. Dec 15, 2022 4 -$2.02M 4 Dec 19, 2022 Chief Executive Officer, Director, 10%+ Owner
FDMT 4D Molecular Therapeutics Inc. Feb 1, 2022 1 $0 4 Feb 3, 2022 Chief Executive Officer, Director, 10%+ Owner